Cardiomyopathy, other and unspecified

I9_CARDMYOOTH

cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.8, I42.9 Hospital discharge: ICD-9 — 4259X Hospital discharge: ICD-8 — 425 Cause of death: ICD-10 — I42.8, I42.9 Cause of death: ICD-9 — 4259X Cause of death: ICD-8 — 425 2 out of 7 registries used, show all original rules.	3324
4. Check minimum number of events None	3324
5. Include endpoints None	3324
6. Filter based on genotype QC (FinnGen only)	3245

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_CARDMYOOTH
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I428\|I429
HD_ICD_9	4259X
HD_ICD_8	425
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I428\|I429
COD_ICD_9	4259X
COD_ICD_8	425
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiomyopathy, other and unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23467	8732	14423
Only index persons	17151	6748	10403
Unadjusted period prevalence (%)
Whole population	0.35	0.25	0.40
Only index persons	0.34	0.25	0.40
Median age at first event (years)
Whole population	60.50	63.47	58.75
Only index persons	60.78	63.42	59.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3245	1334	1911
Unadjusted period prevalence (%)	0.71	0.47	0.88
Median age at first event (years)	60.31	60.90	59.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3324: Matched controls
33240

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX892

NOMESCO Finland

Monitored bed care

6.8

317.0

551

943

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

316.8

299

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

313.6

296

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

992.1

307.7

706

XF404

NOMESCO Finland

Ambulatory ECG

27.5

307.7

923

458

K78

ICPC

Atrial fibrillation/flutter

35.1

307.7

462

152

C09AA05

ATC

ramipril; oral

6.5

307.7

1752

4852

I50

ICD-10 Finland

Heart failure

80.9

307.7

302

C09DX04

ATC

valsartan and sacubitril; oral

+∞

307.7

341

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.8

307.7

1067

2516

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

151.1

307.7

172

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

685.5

307.7

825

C07AB07

ATC

bisoprolol; oral

13.3

307.7

2735

8598

I47.1

ICD-10 Finland

Supraventricular tachycardia

49.9

307.7

215

C03DA01

ATC

spironolactone; oral

23.9

307.7

1541

1161

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

149.8

307.7

300

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

657.2

307.7

1008

I50.9

ICD-10 Finland

Heart failure, unspecified

236.9

307.7

1621

133

C03CA01

ATC

furosemide; systemic

12.2

307.7

2131

4255

I48

ICD-10 Finland

Atrial fibrillation and flutter

232.2

307.7

1512

119

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

307.7

2118

9796

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

655.9

307.7

941

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

349

K77

ICPC

Heart failure

50.2

307.7

203

AN1

Coronary angiography

9.5

307.7

994

1427

XF400

NOMESCO Finland

ECG with 12 standard connections

4.8

307.7

947

2550

B01AF02

ATC

apixaban; oral

13.9

307.7

640

561

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

307.7

1476

I48.1

ICD-10 Finland

Persistent atrial fibrillation

235.0

307.7

260

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

13.0

307.7

1968

3335

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

160.9

307.7

359

B01AA03

ATC

warfarin; systemic

18.0

307.7

1490

1438

C07AA07

ATC

sotalol; systemic

17.0

307.7

281

180

201

Kela drug reimbursment

Chronic cardiac insufficiency

176.5

307.7

1438

143

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

166.8

307.7

397

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

52.8

307.7

245

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

105.7

307.7

254

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

224.1

307.7

268

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

853

I47.2

ICD-10 Finland

Ventricular tachycardia

642.2

307.7

447

I50.1

ICD-10 Finland

Left ventricular failure

3030.5

307.7

942

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

216.1

307.7

203

I49.3

ICD-10 Finland

Ventricular premature depolarization

18.7

307.7

428

261

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

137.9

307.7

379

TFP20

NOMESCO Finland

Cardiodefibrillation

504.9

307.7

617

C01AA05

ATC

digoxin; systemic

70.4

307.7

804

150

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

21.1

307.7

1876

1922

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4503599627370496.0

307.7

2561

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

10.7

307.7

633

714

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

12.0

307.7

1612

2427

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

11.7

307.7

478

470

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

307.7

742

I50.0

ICD-10 Finland

Congestive heart failure

474.3

307.7

900

GD1LA

NOMESCO Finland

165.2

307.7

287

I49.5

ICD-10 Finland

Sick sinus syndrome

221.8

307.7

208

207

Kela drug reimbursment

Chronic arrhythmias

990.4

307.7

1202

C01BD01

ATC

amiodarone; systemic

500.7

307.7

509

C01BC04

ATC

flecainide; systemic

155.9

299.9

149

XF640, ,

NOMESCO Finland

18.1

280.9

230

136

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.8

275.4

474

799

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

1408.7

270.4

260

I48.2

ICD-10 Finland

Chronic atrial fibrillation

573.2

270.4

265

R06.0

ICD-10 Finland

Dyspnoea

3.7

269.8

1218

4472

XF402

NOMESCO Finland

ECG with work load test

5.3

263.7

609

1352

AP1

Catheterization of the left side of the heart

19.7

262.6

206

111

250, ,

Kela drug reimbursment

319.0

262.2

263

Z2221

NOMESCO Finland

Medical doctor

3.5

255.8

1328

5303

I44.2

ICD-10 Finland

Atrioventricular block, complete

2466.4

251.1

240

TFP34

NOMESCO Finland

Electrophysiological investigation

644.3

245.4

240

I35.0

ICD-10 Finland

Aortic (valve) stenosis

24.8

244.7

174

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

833.2

239.7

233

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

7.8

235.7

347

492

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.5

224.9

1039

3809

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

224.6

213

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

10.4

221.1

253

261

Angiography of the heart and coronary arteries

6.4

219.1

391

679

ZXD05

NOMESCO Finland

Urgent procedure

3.2

214.1

1316

5704

I34.1

ICD-10 Finland

Mitral (valve) prolapse

70.0

211.5

115

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

20.1

210.5

163

M04AA01

ATC

allopurinol; systemic

4.0

207.2

715

2147

ZXE00

NOMESCO Finland

One hour or less

2.9

200.6

1638

8245

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

23.1

200.2

146

K84

ICPC

Heart disease other

11.8

199.6

208

187

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

1913.5

198.9

191

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

6.1

196.9

368

667

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

14.7

193.0

175

125

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

92.7

189.2

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

5.2

185.8

422

912

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

927.5

181.0

176

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

7.7

179.0

260

361

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

174.5

166

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

173.5

165

TPH07

NOMESCO Finland

Cathetrisation of artery

3.8

171.5

601

1808

FL1AC

NOMESCO Finland

Left cardioangiography

13.8

162.9

153

116

A10BK01

ATC

dapagliflozin; oral

4.6

161.9

427

1040

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

156.5

149

Z3231

NOMESCO Finland

Registered nurse

2.7

155.5

1204

5725

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

155.4

148

R4110

NOMESCO Finland

Physiotherapy

2.7

154.9

1213

5798

WX872

NOMESCO Finland

Intensive care

6.1

154.3

283

501

ZX120

NOMESCO Finland

Intravenous

3.9

153.6

516

1501

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

152.0

939

3962

XFE00

NOMESCO Finland

Epicardial ultrasonography

12.7

151.4

149

122

A12BA01

ATC

potassium chloride; oral

6.7

148.9

246

392

ZXD10

NOMESCO Finland

Scheduled procedure

2.5

146.2

1546

8490

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

144.9

138

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

139.2

723

2756

TFJ02

NOMESCO Finland

Muscle biopsy of heart

1319.1

131.2

127

M10.9

ICD-10 Finland

Gout, unspecified

4.2

130.4

376

975

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

334.8

129.4

130

127

Kela drug reimbursment

Transplant complication

10.9

129.2

141

135

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

23.0

129.1

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

127.9

122

TFP35

NOMESCO Finland

Electroanatomical mapping

430.2

125.7

125

C07AG02

ATC

carvedilol; oral

4.5

123.2

327

795

L04AA06

ATC

mycophenolic acid; systemic

9.3

121.8

149

167

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

121.6

116

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

121.1

1017

4927

C07AB02

ATC

metoprolol; systemic

2.8

120.6

772

3272

I42

ICD-10 Finland

Cardiomyopathy

+∞

120.5

115

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

609.6

119.9

118

1CX08, ,

NOMESCO Finland

212.8

119.5

123

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.6

118.7

951

4500

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

118.2

1405

7931

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

117.9

724

3000

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

9.9

115.7

135

142

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

+∞

115.3

110

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

114.3

451

1447

Z3226

NOMESCO Finland

Physiotherapist

2.7

113.9

793

3496

XF409

NOMESCO Finland

Other special ECG

63.2

111.9

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

35.7

111.5

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

111.0

1066

5456

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

+∞

110.0

105

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

134.7

109.8

117

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

46.6

108.9

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.5

107.2

281

675

Z94.1

ICD-10 Finland

Heart transplant status

223.2

105.2

108

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

103.7

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.5

103.1

401

1271

B01AE07

ATC

dabigatran etexilate; oral

7.4

100.7

148

207

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.5

99.6

167

269

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.0

99.5

221

463

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

99.5

C08DA01

ATC

verapamil; systemic

6.5

99.2

167

270

R02

ICPC

Shortness of breath/dyspnoea

3.0

98.4

500

1857

C01DA14

ATC

isosorbide mononitrate; oral

2.8

96.1

582

2373

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

486.6

95.9

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

94.2

AP4

Myocardial biopsy

934.1

93.3

B01AF03

ATC

edoxaban; oral

17.7

93.1

B01AB05

ATC

enoxaparin; parenteral

2.2

92.1

1165

6592

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

16.5

90.1

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.2

90.0

135

193

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.5

89.8

336

1036

L04AD02

ATC

tacrolimus; systemic

11.8

89.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.8

89.2

295

838

K99

ICPC

Cardiovascular disease other

7.1

88.7

135

196

TK800

NOMESCO Finland

Hemodialysis

7.0

87.5

136

202

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

86.4

534

2192

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.4

85.2

172

331

AA1AD

NOMESCO Finland

CT of head and brain

2.2

85.1

1002

5480

I25.2

ICD-10 Finland

Old myocardial infarction

3.8

84.2

278

788

3AC01, ,

NOMESCO Finland

12.3

83.3

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.0

82.2

250

669

I51.4

ICD-10 Finland

Myocarditis, unspecified

818.1

81.8

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

81.6

I44.1

ICD-10 Finland

Atrioventricular block, second degree

113.0

81.3

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

80.5

H02AB06

ATC

prednisolone; systemic

2.0

79.1

1616

10742

ZXE20

NOMESCO Finland

More than three and less than five hours

2.6

78.9

555

2420

N19

ICD-10 Finland

Unspecified kidney failure

5.1

78.9

172

354

AS4

Physiological pacemaker insertion DDD (R)

+∞

78.4

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

77.4

AQ1

Conventional electrophysiological examination

+∞

77.4

AS7

Arrhythmia pacemaker insertion VVI (R) S

765.7

76.6

A10BK03

ATC

empagliflozin; oral

2.8

75.8

422

1635

Z2446

NOMESCO Finland

Social worker

3.4

75.3

291

913

WX722

NOMESCO Finland

PEEP

4.0

74.9

227

605

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

74.9

654

3141

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

72.1

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.5

71.7

266

813

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

71.1

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

15.4

70.9

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

70.0

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

70.0

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

6.9

69.6

108

160

R55

ICD-10 Finland

Syncope and collapse

2.7

69.3

420

1697

C09AA04

ATC

perindopril; oral

3.5

69.0

257

787

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.7

68.1

228

651

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

67.9

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

67.8

223

629

A46

ICD-10 Finland

Erysipelas

2.4

67.6

556

2592

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

661.2

66.2

ZX108

NOMESCO Finland

Inhalation

12.0

65.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

65.3

365

1413

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.3

64.7

132

256

Electrophysiological Special Examination

640.3

64.1

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.1

64.0

112

188

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

629.9

63.0

XF600

NOMESCO Finland

Bloodpressure measurement

3.3

62.6

252

809

WX730

NOMESCO Finland

Conventional respirator

7.8

62.5

114

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.0

61.2

109

186

K80

ICPC

Cardiac arrhythmia NOS

3.5

61.0

225

684

I20.09

ICD-10 Finland

Unstable angina

3.4

60.0

224

686

TK810

NOMESCO Finland

Hemofiltration

14.0

59.6

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

59.6

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.3

59.0

156

375

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

58.7

299

1099

M10

ICD-10 Finland

Gout

3.5

58.6

209

621

WX740

NOMESCO Finland

Nitrogen oxide therapy

126.3

58.0

C09AA02

ATC

enalapril; systemic

2.1

58.0

714

3893

I44.0

ICD-10 Finland

Atrioventricular block, first degree

14.7

57.9

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

57.8

942

5663

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

57.8

327

1271

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

57.8

669

3565

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

57.7

614

3168

A11CC03

ATC

alfacalcidol; systemic

5.5

57.6

112

208

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

57.5

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.9

57.1

103

178

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

14.3

57.1

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

56.4

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

6.1

55.7

162

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

55.4

897

5367

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

55.1

397

1735

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

55.0

394

1717

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

54.8

640

3415

B01AF01

ATC

rivaroxaban; oral

2.5

54.7

397

1740

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.0

54.7

165

E87.5

ICD-10 Finland

Hyperkalaemia

6.6

54.6

139

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

54.3

M10.0

ICD-10 Finland

Idiopathic gout

4.0

54.0

159

414

R04.0

ICD-10 Finland

Epistaxis

2.9

53.6

275

1014

Initial pacemaker installation

+∞

53.3

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

53.3

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

52.7

149

377

I49.1

ICD-10 Finland

Atrial premature depolarization

6.9

52.6

122

I45.9

ICD-10 Finland

Conduction disorder, unspecified

96.7

52.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.0

51.2

244

863

42508

ICD-8 Finland

Cardiomyopathy, Alia definita

+∞

51.2

Z50.0

ICD-10 Finland

Cardiac rehabilitation

8.5

51.1

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

4.9

51.1

115

243

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

505.5

50.5

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.3

50.4

199

630

R53

ICD-10 Finland

Malaise and fatigue

2.0

50.3

712

4056

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

50.1

401

1833

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.6

49.9

170

490

N18.8

ICD-10 Finland

Other chronic renal failure

5.1

49.6

106

214

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

49.1

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

6.5

49.0

125

AP2

Catheterization of the right side of the heart

91.5

48.9

C10AA05

ATC

atorvastatin; oral

1.7

48.0

1419

10067

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

48.0

836

5087

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.8

48.0

112

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.1

47.9

209

703

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

47.6

946

5990

WX882

NOMESCO Finland

High dependency care

4.2

46.8

129

320

AP3

Catheterization of the right and left side of the heart

464.2

46.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.8

45.7

243

912

L04AX01

ATC

azathioprine; systemic

3.4

45.6

168

509

A02BC02

ATC

pantoprazole; systemic

1.7

45.2

2150

17199

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

66.0

45.2

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

44.9

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

+∞

44.9

C10AA01

ATC

simvastatin; oral

1.7

44.8

1459

10562

H03BB01

ATC

carbimazole; oral

3.6

44.3

148

421

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

44.1

184

602

RS221, ,

NOMESCO Finland

5.9

44.0

136

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.1

43.7

186

616

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

433.2

43.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

42.9

317

1395

C08DB01

ATC

diltiazem; oral

3.1

41.8

179

595

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

41.7

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

41.7

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

41.7

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

4.2

41.5

113

278

WX002

NOMESCO Finland

Sedation and analgesia

1.9

40.8

656

3866

L04AD01

ATC

ciclosporin; systemic

4.9

40.8

187

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

+∞

40.7

Cardiac muscle biopsy

+∞

40.7

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.9

40.6

123

327

R03AC02

ATC

salbutamol; inhalant

1.6

40.5

1602

12078

S97

ICPC

Chronic ulcer skin

2.8

40.3

216

813

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

40.0

231

903

R03BB04

ATC

tiotropium bromide; inhalant

2.2

39.8

359

1719

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.6

39.7

132

374

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

39.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.7

39.6

227

885

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

39.5

359

1723

Catheterization and pressure measurement of the left side of the heart

5.5

39.4

140

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

13.4

39.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

39.0

523

2900

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

38.9

557

3159

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

11.6

38.7

7AX01, ,

NOMESCO Finland

381.7

38.1

3A064, ,

NOMESCO Finland

85.1

37.9

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.8

37.3

118

323

N02AX02

ATC

tramadol; systemic, rectal

1.6

37.3

1376

10134

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

37.2

188

686

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

361.2

36.0

I20.00

ICD-10 Finland

Unstable angina

3.8

36.0

110

294

E05.89

ICD-10 Finland

Other thyrotoxicosis

69.0

36.0

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

35.8

243

1027

H02AB07

ATC

prednisone; oral

2.0

35.8

451

2444

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

35.5

AS2

Ventricular pacemaker insertion VVI (R)

+∞

35.5

132

Kela drug reimbursment

Sarcoidosis

8.9

35.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

35.4

214

856

R2110

NOMESCO Finland

Giving the first information

2.7

35.4

204

797

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.0

35.1

164

573

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.4

34.5

239

1020

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

34.4

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

+∞

34.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

34.4

195

755

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

34.3

340

1687

J01FF01

ATC

clindamycin; systemic

1.7

34.2

821

5401

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

34.0

1021

7113

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

33.8

193

750

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

33.8

164

585

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

33.8

344

1724

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

33.6

154

532

Initial installation of the atrial pacemaker

+∞

33.4

Catheter ablation of arrhythmia

+∞

33.4

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

33.4

C09AA01

ATC

captopril; oral

4.9

33.2

155

N17.8

ICD-10 Finland

Other acute renal failure

6.2

33.2

N05CF01

ATC

zopiclone; oral

1.6

33.1

1008

7036

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

10.7

33.1

R4190

NOMESCO Finland

Nutritional therapy

3.1

32.4

140

468

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

32.1

216

909

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

32.0

881

5992

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.0

32.0

137

R50.9

ICD-10 Finland

Fever, unspecified

1.9

31.9

456

2572

Catheterization and pressure measurement of the right side of the heart

72.9

31.9

Z71.8

ICD-10 Finland

Other specified counselling

1.6

31.7

862

5840

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

31.3

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

31.3

AQ2

Electrophysiological electroanatomical examination

+∞

31.3

342

Kela drug reimbursment

Dronedarone

+∞

31.3

J01MA12

ATC

levofloxacin; systemic

1.8

31.1

591

3635

A10AE04

ATC

insulin glargine; parenteral

2.1

30.7

315

1580

WX890

NOMESCO Finland

Intesive care monitoring

8.1

30.7

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

6.9

30.5

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

30.5

112

339

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

30.4

2291

25867

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

30.2

K83

ICPC

Heart valve disease NOS

32.9

30.0

PD5AD

NOMESCO Finland

CT of aorta

4.6

29.9

157

I11

ICD-10 Finland

Hypertensive heart disease

12.1

29.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.7

29.6

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

37.4

29.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

29.2

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

29.2

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

29.2

K04

ICPC

Palpitations/awareness of heart

3.0

29.1

129

437

J01DB01

ATC

cefalexin; oral

1.6

29.1

2543

22217

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

29.0

150

554

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

29.0

124

412

742, ,

NOMESCO Finland

80.9

28.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

28.8

1222

9142

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

28.8

253

1195

ZXA05

NOMESCO Finland

Left side

1.6

28.7

782

5281

I48.3

ICD-10 Finland

Typical atrial flutter

151.3

28.7

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.7

28.3

243

TFN04, ,

NOMESCO Finland

10.1

28.3

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

28.2

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

28.2

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

28.2

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

28.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

28.1

362

1968

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.7

28.0

G04BE03

ATC

sildenafil; oral

3.8

27.9

236

J01CA04

ATC

amoxicillin; systemic

1.6

27.8

2424

21019

A10AB05

ATC

insulin aspart; parenteral

2.2

27.8

241

1131

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

42.9

27.7

L04AA01

ATC

[U] ciclosporin

4.8

27.6

131

A10AC01

ATC

insulin (human); parenteral

2.2

27.6

231

1069

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

27.4

936

6658

R4120

NOMESCO Finland

Occupational therapy

2.3

27.3

220

1002

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.2

27.3

111

358

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

27.1

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

27.1

XFP02, ,

NOMESCO Finland

+∞

27.1

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

27.1

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

27.1

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

27.1

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

27.1

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.6

27.0

251

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

5.1

26.8

111

C03AA03

ATC

hydrochlorothiazide; oral

2.1

26.8

276

1385

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

26.8

651

4263

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

273.2

26.8

N18.0

ICD-10 Finland

End-stage renal disease

6.9

26.7

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.2

26.7

106

337

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

141.2

26.6

C01BA03

ATC

disopyramide; systemic

46.1

26.5

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

6.6

26.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

26.2

126

447

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

23.4

26.1

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

26.1

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

25.7

796

5522

R42

ICD-10 Finland

Dizziness and giddiness

1.6

25.7

656

4346

C01BD07

ATC

dronedarone; oral

+∞

25.0

N02BE01

ATC

paracetamol; systemic, rectal

1.6

24.9

2762

24899

B01AB04

ATC

dalteparin; parenteral

2.4

24.7

175

753

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

24.7

182

797

A10BA02

ATC

metformin; oral

1.5

24.7

894

6414

ZXE90

NOMESCO Finland

More than 22 hours

7.8

24.7

L28

ICPC

Limited function/disability (L)

1.7

24.5

534

3392

UJF32

NOMESCO Finland

Coloscopy

1.6

24.4

785

5484

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

24.4

552

3541

C01BB02

ATC

mexiletine; systemic

48.7

24.3

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

7.9

24.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

24.3

230

1118

GEA00

NOMESCO Finland

Mediastinoscopy

9.7

24.1

K29

ICPC

Cardiovascular sympt/complt other

2.6

24.0

138

538

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

24.0

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

+∞

24.0

XF406

NOMESCO Finland

High resolution ECG

+∞

24.0

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

24.0

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

24.0

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

24.0

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

24.0

C01BA01

ATC

quinidine; oral

37.8

23.9

C09CA03

ATC

valsartan; oral

1.9

23.8

297

1596

K05

ICPC

Irregular heartbeat other

3.7

23.6

211

C07AB03

ATC

atenolol; systemic

2.4

23.6

173

756

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

23.6

205

963

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

23.5

1301

10156

R04.2

ICD-10 Finland

Haemoptysis

2.7

23.5

125

469

ZXD00

NOMESCO Finland

Emergency procedure

3.0

23.2

101

339

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

23.2

124

466

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

22.9

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

22.9

I51.9

ICD-10 Finland

Heart disease, unspecified

65.4

22.8

WW200

NOMESCO Finland

Immunization

3.1

22.7

307

FXE00

NOMESCO Finland

Use of ECLA

231.5

22.6

I45.6

ICD-10 Finland

Pre-excitation syndrome

231.5

22.6

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

120.9

22.6

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.5

22.4

125

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

22.4

146

3025

Kela drug reimbursment

Calcium carbonate

9.1

22.1

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

22.1

181

830

A28

ICPC

Limited function/disability NOS

1.6

22.0

515

3325

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

+∞

21.9

AK1

HTX (heart transplant)

+∞

21.9

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

80.7

21.7

I44.6

ICD-10 Finland

Other and unspecified fascicular block

115.8

21.6

WX902

NOMESCO Finland

External defibrillation of heart

115.8

21.6

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.4

21.5

125

M01AH05

ATC

etoricoxib; oral

0.7

21.5

1285

15781

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

21.4

206

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

8.3

21.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

21.3

231

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.7

21.3

113

423

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

21.2

196

943

A12AA04

ATC

calcium carbonate; oral

4.3

21.1

131

B01AC04

ATC

clopidogrel; oral

1.7

21.0

484

3110

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

21.0

393

2389

A10AE05

ATC

insulin detemir; parenteral

2.3

21.0

163

731

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

20.9

153

668

J81

ICD-10 Finland

Pulmonary oedema

16.7

20.9

R60.0

ICD-10 Finland

Localized oedema

1.8

20.9

349

2053

FM1CD

NOMESCO Finland

Very extensive CT of heart

60.4

20.9

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

20.9

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

20.9

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

20.9

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

+∞

20.9

I51.7

ICD-10 Finland

Cardiomegaly

+∞

20.9

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

20.9

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

+∞

20.9

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

+∞

20.9

FM1DE, ,

SPAT

24.4

20.8

XF602

NOMESCO Finland

Bloodpressure monitoring

4.6

20.8

108

ZX197, ,

NOMESCO Finland

77.3

20.7

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

20.7

146

628

J96.0

ICD-10 Finland

Acute respiratory failure

4.9

20.6

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

110.7

20.6

I95.9

ICD-10 Finland

Hypotension, unspecified

4.0

20.5

147

RS222, ,

NOMESCO Finland

4.5

20.5

109

RS220, ,

NOMESCO Finland

4.3

20.4

126

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

20.4

752

5382

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.6

20.4

R00.2

ICD-10 Finland

Palpitations

2.2

20.1

164

750

R07.3

ICD-10 Finland

Other chest pain

1.9

20.1

278

1544

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

20.0

207

1039

J94.8

ICD-10 Finland

Other specified pleural conditions

4.0

20.0

141

I95.2

ICD-10 Finland

Hypotension due to drugs

6.8

20.0

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

19.8

136

577

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

19.8

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

+∞

19.8

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

19.8

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

19.7

387

2382

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

19.7

355

5AB14, ,

NOMESCO Finland

29.1

19.6

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

19.6

104

390

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

105.7

19.6

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

7.1

19.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

19.5

300

1722

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

21.7

19.5

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

19.4

401

2501

G47.3

ICD-10 Finland

Sleep apnoea

1.5

19.4

656

4603

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.5

19.4

106

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

19.4

223

1164

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.9

19.4

149

ZXA00

NOMESCO Finland

Right side

1.5

19.3

794

5806

C08CA02

ATC

felodipine; oral

1.8

19.2

282

1596

T92

ICPC

Gout

3.2

19.2

242

C02EA01, ,

ATC

4.7

19.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

19.1

326

1928

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

19.1

118

477

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.1

19.1

258

5253

FHL

Cardiac lung machine

7.0

19.1

XG466

NOMESCO Finland

Sleep oxymetry

2.8

19.1

350

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

7.2

19.1

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

19.0

157

722

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

19.0

951

7214

205

Kela drug reimbursment

Chronic hypertension

1.5

18.9

803

5902

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.5

18.9

104

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

18.8

1853

15793

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

18.8

XX3BW, ,

NOMESCO Finland

+∞

18.8

AS5

Biventricular heart failure pacemaker insertion VVI (R)

+∞

18.8

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

18.8

AB2

AVR bio, stent

+∞

18.8

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

18.8

238

1284

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

18.8

184

906

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

18.7

183

900

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.2

18.6

Z94.0

ICD-10 Finland

Kidney transplant status

4.5

18.4

E66.8

ICD-10 Finland

Other obesity

2.4

18.3

132

573

K92.1

ICD-10 Finland

Melaena

2.2

18.3

161

760

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

44.2

18.2

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

18.2

142

638

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.2

18.1

112

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

18.0

1142

9019

C02DE01, ,

ATC

6.3

18.0

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

33.1

17.9

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

17.9

1055

8226

WVA20

NOMESCO Finland

Medicine administration

2.9

17.9

290

NHQ40

NOMESCO Finland

Amputation of toe

3.8

17.8

140

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.1

17.7

118

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.7

17.7

AC4

MVP

+∞

17.7

C10AA03

ATC

pravastatin; oral

1.9

17.7

222

1193

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

17.6

374

2347

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

17.6

309

I45.3

ICD-10 Finland

Trifascicular block

95.6

17.6

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

180.9

17.5

F1279, ,

NOMESCO Finland

180.9

17.5

A10BH05

ATC

linagliptin; oral

2.2

17.5

154

727

RS230, ,

NOMESCO Finland

6.6

17.5

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.2

17.4

111

R11

ICD-10 Finland

Nausea and vomiting

1.9

17.4

220

1185

T90

ICPC

Diabetes non-insulin dependent

1.5

17.2

724

5297

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.3

17.2

191

N05BA01

ATC

diazepam; systemic, rectal

1.7

17.2

366

2299

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

17.2

207

1098

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

17.1

158

760

TGC00

NOMESCO Finland

Bronchial lavation

2.8

17.1

319

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

17.1

244

1367

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.7

17.0

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

17.0

498

3379

I49.2

ICD-10 Finland

Junctional premature depolarization

50.3

17.0

WX402

NOMESCO Finland

General anaesthesia

1.5

17.0

566

3950

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

16.9

340

2105

E66.9

ICD-10 Finland

Obesity, unspecified

2.7

16.8

339

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

22.0

16.8

AA1

Conventional CABG

3.4

16.8

179

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

16.8

128

570

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

63.7

16.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

16.7

140

648

J01MA14

ATC

moxifloxacin; systemic

1.8

16.7

255

1459

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

16.7

C01BC03

ATC

propafenone; systemic

+∞

16.7

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

16.7

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.4

16.6

112

472

SPAT1263

SPAT

Sampling

1.4

16.6

1110

8818

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.5

16.6

102

412

3A149, ,

NOMESCO Finland

90.5

16.6

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

170.8

16.5

120, ,

NOMESCO Finland

170.8

16.5

I45.2

ICD-10 Finland

Bifascicular block

27.7

16.5

A10BH01

ATC

sitagliptin; oral

1.7

16.5

296

1776

S18

ICPC

Laceration/cut

1.4

16.4

1345

11034

J01AA02

ATC

doxycycline; systemic

1.4

16.4

2330

20843

K79

ICPC

Paroxysmal tachycardia

20.1

16.4

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

5.7

16.3

5CM18, ,

NOMESCO Finland

14.3

16.3

A10BB12

ATC

glimepiride; oral

1.9

16.3

206

1111

C09CA01

ATC

losartan; oral

1.4

16.2

742

5510

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

16.2

285

1699

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

16.2

284

SPAT1251

SPAT

Organisation of medication

2.6

16.1

370

C10AX09

ATC

ezetimibe; oral

1.6

16.0

452

3040

212

Kela drug reimbursment

Gout

3.0

16.0

237

E86

ICD-10 Finland

Volume depletion

2.9

15.8

260

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

33.5

15.7

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

15.7

221

1234

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.8

15.7

289

R06

ICPC

Nose bleed/epistaxis

3.0

15.6

229

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

15.6

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

+∞

15.6

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

15.6

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

15.6

AT7

Replacing the pacemaker VVI (R) S

+∞

15.6

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

15.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

15.6

199

1075

XF622

NOMESCO Finland

Measurement of minute volume of heart

13.8

15.5

AA5PD

NOMESCO Finland

CT examination of brain pefusion

5.0

15.5

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

15.4

507

3523

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

15.4

731

5459

2BD01, ,

NOMESCO Finland

38.2

15.4

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

15.3

152

752

A07AA02

ATC

nystatin; oral

2.0

15.3

171

883

FN1AD

NOMESCO Finland

CT of coronary arteries

3.5

15.3

146

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.4

15.2

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.3

15.1

Q23.11

ICD-10 Finland

Bicuspid aortic valve

20.1

15.1

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

4.1

15.0

102

GBB00

NOMESCO Finland

Tracheostomy

3.6

14.9

134

R18

ICD-10 Finland

Ascites

2.9

14.9

252

A04

ICPC

Weakness/tiredness general

1.6

14.9

351

2260

J20

ICD-10 Finland

Acute bronchitis

1.7

14.9

263

1570

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

5.2

14.8

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

5.2

14.8

SPAT1097

SPAT

Recording of ECG

1.6

14.8

376

2464

FXG00

NOMESCO Finland

Insertion and use of IABP

25.1

14.7

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

21.1

14.6

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

+∞

14.6

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.5

14.5

146

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

14.5

156

795

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

14.5

223

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.4

14.5

AR5

Catheter ablation of arrhythmia, target: atrial flutter

150.6

14.5

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.6

14.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

14.4

409

J01DA01

ATC

[U] cefalexin

1.3

14.2

1750

15140

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.6

14.1

125

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.4

14.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.0

1408

11823

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

14.0

249

1488

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.7

14.0

K06.18

ICD-10 Finland

Another gingival hyperplasia

6.7

14.0

J45

ICD-10 Finland

Asthma

1.7

14.0

247

1473

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

14.0

378

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.1

13.9

191

RD210, ,

NOMESCO Finland

3.1

13.9

181

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

13.9

467

3257

M79.6

ICD-10 Finland

Pain in limb

1.3

13.9

1109

9003

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

13.8

344

A01

ICPC

Pain general/multiple sites

1.7

13.8

243

1449

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.7

13.8

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

13.7

406

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

13.7

182

998

SPAT1260

SPAT

Consultation of another employee

1.5

13.6

455

3166

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.5

13.6

133

I44.4

ICD-10 Finland

Left anterior fascicular block

75.4

13.6

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

13.6

254

1540

JN4AD

NOMESCO Finland

Body CT examination

1.6

13.6

290

1821

A10AD05

ATC

insulin aspart; parenteral

3.2

13.6

168

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

+∞

13.5

Aortic Valve Replacement (AVR)

+∞

13.5

K60

ICPC

Cardiovascular, Result test/procedure

5.5

13.5

ZXA10

NOMESCO Finland

Bilateral

1.5

13.5

520

3725

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.1

13.5

121

577

A06AD11

ATC

lactulose; oral

1.5

13.4

426

2932

SPAT1255

SPAT

Intravenous administration of medicine

1.8

13.4

187

1040

A10BJ02

ATC

liraglutide; parenteral

2.5

13.4

325

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

3.6

13.3

125

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.7

13.3

279

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

13.3

195

1102

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

6.3

13.3

K28

ICPC

Limited function/disability (K)

2.8

13.2

246

SPAT1254

SPAT

Administration of medicine

1.6

13.2

371

2486

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.2

13.2

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.3

13.1

100

446

H02AB04

ATC

methylprednisolone; systemic

1.6

13.1

369

2474

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.8

13.1

242

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

3.7

13.1

108

X57

ICD-10 Finland

Unspecified privation

2.9

13.1

220

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.6

13.0

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.0

13.0

193

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

13.0

2015

17901

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.0

1100

8986

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

13.0

128

633

FM1AD

NOMESCO Finland

CT of heart

28.5

12.9

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

12.9

152

800

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

12.9

141

724

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

12.9

145

752

N05BA04

ATC

oxazepam; oral

1.4

12.8

670

5070

Z2445

NOMESCO Finland

Psychologist

2.2

12.8

103

470

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.8

366

2462

WX900

NOMESCO Finland

Resuscitation

11.6

12.8

A41.8

ICD-10 Finland

Other specified sepsis

2.9

12.8

201

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

10.5

12.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

12.7

122

597

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.9

12.6

213

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

15.5

12.6

SPAT1325

SPAT

Vaccination

1.3

12.6

925

7392

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

12.6

253

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

12.5

114

547

AD1

TVP

+∞

12.5

FA1AC

NOMESCO Finland

Upper cavography

+∞

12.5

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

12.5

4278X

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[DYSRHYTMIAE CORDIS ALIA DEFINITA]

+∞

12.5

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

+∞

12.5

I40.0

ICD-10 Finland

Infective myocarditis

+∞

12.5

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

12.5

K90

ICPC

Stroke/cerebrovascular accident

2.4

12.5

367

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

12.5

392

R03BA02

ATC

budesonide; inhalant

1.5

12.4

438

3080

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.1

12.4

162

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.1

12.4

162

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

12.3

340

2268

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

12.3

388

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.3

12.3

137

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.9

12.3

189

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

12.3

104

485

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.6

12.3

113

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

12.2

421

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.7

12.1

229

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

15.9

12.1

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.5

12.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

12.1

198

1157

J01FA06

ATC

roxithromycin; oral

1.3

12.1

1052

8609

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

11.1

12.0

I45.0

ICD-10 Finland

Right fascicular block

10.1

12.0

SPAT1285

SPAT

Provision of consultation response

1.9

11.9

141

744

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.1

11.8

161

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

11.8

755

5897

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.4

11.8

121

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.3

11.7

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

11.7

268

1712

5BA08, ,

NOMESCO Finland

4.9

11.7

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

11.7

149

807

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.7

432

3066

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.4

11.6

117

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

65.2

11.6

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

11.6

160

888

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

11.6

190

H02AB09

ATC

hydrocortisone; systemic

2.5

11.5

294

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

11.5

380

2634

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.5

11.5

113

M10.3

ICD-10 Finland

Gout due to impairment of renal function

11.1

11.5

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

11.5

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

11.5

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

11.5

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

+∞

11.5

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

11.5

5244

FHL

Heart transplantation

+∞

11.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

11.5

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

11.5

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

120.4

11.4

J01MA02

ATC

ciprofloxacin; systemic

1.3

11.4

1114

9242

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.8

11.4

EB1WA, ,

NOMESCO Finland

4.5

11.4

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

11.3

365

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

11.2

443

SPAT1262

SPAT

Handing over of treatment supplies

1.4

11.2

492

3605

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.7

11.2

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.6

11.2

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

25.1

11.1

I45.8

ICD-10 Finland

Other specified conduction disorders

25.1

11.1

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.7

11.1

R03BA01

ATC

beclometasone; inhalant

1.5

11.1

346

2370

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

11.0

423

3021

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.8

11.0

201

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

11.0

289

1908

C02EA02, ,

ATC

2.0

10.9

115

583

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.3

10.9

359

M04AA03

ATC

febuxostat; oral

11.9

10.8

Q21.10

ICD-10 Finland

Persistent ostium secundum

15.5

10.8

3A422, ,

NOMESCO Finland

28.1

10.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.7

10.7

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.4

10.7

114

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

10.7

466

V03AE01

ATC

polystyrene sulfonate; oral

3.3

10.7

119

AB1

AVR mechanical

60.2

10.6

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.3

10.6

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.5

10.6

105

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

10.5

119

619

ZYC03

NOMESCO Finland

Remote contact, text-based

4.8

10.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

10.5

189

1136

R07.2

ICD-10 Finland

Precordial pain

2.5

10.4

242

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

110.4

10.4

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

110.4

10.4

TK830

NOMESCO Finland

Ultrafiltration

110.4

10.4

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

10.4

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

+∞

10.4

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

10.4

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

10.4

WW500

NOMESCO Finland

Blood transfusion

2.0

10.4

111

566

SPAT1229

SPAT

Assessment of need for aid

1.7

10.4

202

1238

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

10.3

354

XG405

NOMESCO Finland

Education on PEF monitoring

2.9

10.3

169

N18

ICD-10 Finland

Chronic kidney disease

3.8

10.3

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

10.3

342

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.3

494

3674

G71.08

ICD-10 Finland

Other muscular dystrophy

18.8

10.3

SPAT1281

SPAT

Other administrative function

1.7

10.2

201

1236

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

10.2

132

719

XF620

NOMESCO Finland

Examination of circulation with color method

7.5

10.2

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.6

10.1

228

R05

ICPC

Cough

1.4

10.1

596

4584

A11

ICPC

Chest pain NOS

1.7

10.1

204

1264

A02BC01

ATC

omeprazole; systemic

1.3

10.1

717

5675

349

Kela drug reimbursment

Febuxostat

11.3

10.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

10.0

333

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

10.0

200

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

10.0

200

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.6

10.0

212

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

40.2

10.0

3A560, ,

NOMESCO Finland

40.2

10.0

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

10.0

138

768

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

9.9

201

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

9.9

118

625

ZY000

NOMESCO Finland

Hospital inpatient

3.4

9.8

105

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.9

9.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.8

335

2336

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

9.8

208

1304

WX213

NOMESCO Finland

Lower leg blockade

4.4

9.8

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.9

9.8

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

4.5

9.8

J01CF05

ATC

flucloxacillin; systemic

1.8

9.7

150

862

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.7

390

2806

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

9.7

103

525

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.1

9.7

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

9.7

163

961

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

9.7

291

1978

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

9.6

131

725

G72.9

ICD-10 Finland

Myopathy, unspecified

3.7

9.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

9.6

260

1728

E66.0

ICD-10 Finland

Obesity due to excess calories

3.9

9.6

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

9.6

139

785

E85.9

ICD-10 Finland

Amyloidosis, unspecified

11.4

9.5

J46

ICD-10 Finland

Status asthmaticus

2.4

9.5

259

288

Kela drug reimbursment

Febuxostat

9.1

9.5

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.8

9.5

R03BA05

ATC

fluticasone; inhalant

1.4

9.5

427

3139

5401

FHL

Pacemaker installation, transvenous electrode

100.3

9.4

ASX

Other pacemaker insertion

+∞

9.4

TFP43

NOMESCO Finland

Ablation treatment for atrial tachycardia

+∞

9.4

5403

FHL

Replacing the pacemaker

+∞

9.4

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

+∞

9.4

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

9.4

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

9.4

Z94.3

ICD-10 Finland

Heart and lungs transplant status

+∞

9.4

4263A

ICD-9 Finland

Conduction disorders, Other left bundle branch block

+∞

9.4

I40.8

ICD-10 Finland

Other acute myocarditis

+∞

9.4

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

9.4

N03AX16

ATC

[U] pregabalin

1.3

9.4

604

4704

N05CD07

ATC

temazepam; oral

1.5

9.3

315

2195

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

9.3

187

1158

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

9.5

9.3

W19

ICD-10 Finland

Unspecified fall

1.5

9.3

249

1652

GD1UN

NOMESCO Finland

Lung circulation SPECT

7.3

9.2

D07AB08

ATC

desonide; topical

1.5

9.2

263

1770

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.1

1871

16842

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

3.6

9.1

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

3.1

9.1

116

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

9.0

217

474, ,

NOMESCO Finland

36.8

9.0

I27.0

ICD-10 Finland

Primary pulmonary hypertension

36.8

9.0

K22

ICPC

Risk factor cardiovascular disease

1.7

9.0

154

914

R94.3

ICD-10 Finland

Abnormal results of cardiovascular function studies

3.6

8.9

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

12.6

8.9

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

12.6

8.9

B01AB10

ATC

tinzaparin; parenteral

1.5

8.8

262

1775

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

8.8

256

1727

41299

ICD-8 Finland

Chronic ischaemic heart disease, Without mention of hypertensive disease

8.6

8.8

137

Kela drug reimbursment

Uraemia requiring dialysis

3.8

8.8

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.8

8.8

E87.6

ICD-10 Finland

Hypokalaemia

2.1

8.7

393

-69

ICPC

Other reason for encounter NEC

2.0

8.7

482

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027456) Digoxin [Moles/volume] in Serum or Plasma

274

90.40

307.65

2.9

1.6

0.81

1.03

nmol/l

—

200

(3022948) Iron [Moles/volume] in Serum or Plasma

1265

3267

5.64

307.65

3.5

2.2

13.31

13.70

umol/l

0.83

1207

3031

(3022217) INR in Platelet poor plasma by Coagulation assay

2224

10706

4.26

307.65

37.2

5.9

1.55

1.10

inr

49.88

608

2928

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1318

4217

4.52

307.65

7.2

2.8

581.11

472.63

ng/l

0.29

1237

3235

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1229

2981

5.95

307.65

3.5

2.1

2.30

g/l

0.01

1167

2746

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2374

5383

12.93

307.65

7.6

1.8

2402.77

515.04

ng/l

45.55

2238

4335

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1040

1526

9.46

307.65

5.1

1.8

362.61

85.03

ng/l

34.43

1010

1344

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1222

2783

6.36

307.65

3.5

2.2

22.80

24.30

2.65

1116

2365

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1115

3649

4.09

296.11

6.9

3.4

0.82

0.81

mmol/l

0.15

1060

3406

(3020779) Urea [Moles/volume] in Serum or Plasma

745

1917

4.72

270.45

16.1

6.0

11.82

8.83

mmol/l

18.67

718

1824

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

360

539

7.37

232.80

5.0

2.6

0.35

0.34

u/ml

0.07

225

282

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

335

508

7.22

213.73

3.3

1.7

11.98

10.87

mg/l

1.43

313

468

(3000991) Gas panel - Venous blood

657

1822

4.25

212.93

13.5

7.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1717

8700

3.01

210.45

6.4

2.7

56.09

96.78

ng/l

0.36

1395

5995

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1290

5701

3.06

200.30

2.8

2.0

2.92

2.81

mg/l

0.82

1141

4754

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1777

9359

2.93

199.68

4.1

2.5

182.79

157.15

ug/l

0.92

1685

8544

(3014111) Lactate [Moles/volume] in Serum or Plasma

644

1898

3.97

190.50

12.0

6.0

1.48

1.31

mmol/l

2.60

625

1850

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

596

1684

4.09

186.81

3.6

1.8

20.68

6.26

ug/l

6.25

541

1431

(3003458) Phosphate [Moles/volume] in Serum or Plasma

826

2918

3.44

185.57

8.6

5.2

1.10

1.01

mmol/l

13.25

778

2716

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

421

986

4.74

167.81

5.7

3.7

23.92

24.07

mmol/l

0.36

414

968

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

405

920

4.87

167.55

3.2

1.7

33.83

39.67

u/l

5.10

311

821

(3018677) aPTT in Platelet poor plasma by Coagulation assay

872

3391

3.13

164.94

4.9

1.8

31.85

29.03

25.90

854

3294

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

711

2532

3.30

155.14

12.1

6.5

4.99

5.09

kpa

1.78

680

2422

(3033658) Prothrombin time (PT) actual/Normal

1296

6414

2.67

154.20

6.1

3.6

74.46

93.60

88.95

1263

6274

(3018418) pH of Serum or Plasma

1425

7398

2.62

153.58

6.0

3.7

7.40

0.91

254

1323

(3027801) Oxygen [Partial pressure] in Arterial blood

708

2533

3.28

153.15

12.1

6.5

11.40

12.87

kpa

12.04

676

2424

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

694

2458

3.30

152.60

2.2

1.7

—

(3003396) Base excess in Arterial blood by calculation

704

2518

3.28

152.28

12.1

6.5

0.56

0.96

mmol/l

1.39

588

1957

(3021447) Carbon dioxide [Partial pressure] in Venous blood

610

2001

3.51

151.59

5.6

3.3

5.92

5.78

kpa

2.68

596

1948

(3023368) Bacteria identified in Blood by Culture

1316

6620

2.64

150.74

6.1

3.9

—

(3002032) Base excess in Venous blood by calculation

607

1996

3.50

150.19

5.6

3.3

1.81

1.87

mmol/l

0.13

529

1659

(3012544) pH of Venous blood

614

2059

3.43

147.09

5.6

3.3

7.38

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1892

11387

2.54

147.01

10.7

5.2

1.19

1.22

mmol/l

29.60

1799

10256

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

872

3599

2.93

146.31

2.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

684

2462

3.24

145.90

2.1

1.6

—

(3016502) Oxygen saturation in Arterial blood

642

2244

3.31

143.59

12.9

6.9

94.88

96.12

3.71

629

2163

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

427

1142

4.14

142.49

15.1

8.2

24.10

24.24

mmol/l

0.33

408

1117

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

410

1102

4.10

135.65

3.9

3.2

4.18

4.53

pmol/l

7.85

376

970

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2039

12991

2.47

135.59

9.4

6.4

14.05

11.63

umol/l

10.97

1968

12342

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

689

2610

3.07

133.68

7.6

4.4

264.09

238.35

u/l

2.83

656

2451

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

373

956

4.27

131.44

1.9

1.6

1.62

1.60

g/l

0.15

328

822

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1986

12633

2.42

130.55

11.4

5.9

1.20

1.22

mmol/l

30.37

1718

10740

(40758558) Short blood count panel - Blood

1232

6359

2.49

129.53

9.4

6.9

—

(3021589) Normoblasts [#/volume] in Blood

1821

11194

2.39

128.80

13.9

8.7

0.00

e9/l

0.02

1479

9103

(3013826) Glucose [Moles/volume] in Serum or Plasma

2201

14751

2.46

127.13

9.1

4.0

6.85

6.76

mmol/l

1.16

2120

13763

(3001604) Monocytes [#/volume] in Blood

1938

12301

2.38

126.45

8.8

5.7

0.63

0.60

e9/l

3.48

1685

10517

(3006315) Basophils [#/volume] in Blood

1938

12336

2.37

125.10

8.8

5.7

0.04

e9/l

0.95

1684

10547

(3019198) Lymphocytes [#/volume] in Blood

1962

12660

2.34

121.16

8.9

5.7

1.76

1.97

e9/l

3.87

1736

11056

(3013115) Eosinophils [#/volume] in Blood

1969

12770

2.33

119.47

9.4

5.9

0.19

0.20

e9/l

2.45

1737

11054

(3022096) Basophils/100 leukocytes in Blood

1797

11222

2.31

119.22

9.1

6.0

0.64

0.68

2.35

1721

10372

(3006504) Eosinophils/100 leukocytes in Blood

1829

11586

2.29

116.18

9.1

5.9

2.71

2.94

4.39

1755

10728

(3019069) Monocytes/100 leukocytes in Blood

1835

11651

2.28

115.76

9.3

6.2

9.02

8.75

3.23

1760

10808

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

264

573

4.92

114.29

4.9

2.5

3.45

3.54

g/l

0.42

251

549

(3036489) Thrombin time

312

795

4.23

110.28

4.4

1.9

22.45

21.04

1.87

289

705

(3002030) Lymphocytes/100 leukocytes in Blood

1852

11962

2.24

109.92

9.2

6.0

24.81

28.12

31.98

1779

11121

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

298

738

4.34

109.35

4.2

2.1

1031.64

586.39

ug/l

0.40

290

694

(3018010) Neutrophils/100 leukocytes in Blood

1831

11794

2.23

109.12

9.0

5.8

59.96

56.79

24.98

1756

10967

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

257

570

4.80

108.31

5.4

2.4

211.82

185.80

4.26

252

543

(3044889) 12 lead EKG panel

2495

18391

2.43

105.58

7.3

3.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

473

1639

3.20

105.32

4.7

2.8

4.66

4.54

kpa

0.45

457

1590

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1298

7377

2.25

104.26

2.9

2.0

380.61

214.03

u/l

0.78

1234

6875

(3052851) Hemolysis interference index of Serum or Plasma

275

674

4.36

102.14

4.6

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1260

7128

2.24

101.82

3.9

3.0

1.00

0.42

e6/l

2.37

983

5359

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

964

4911

2.36

99.68

4.8

1.6

1.49

1.31

mg/l

0.64

752

3806

(3013650) Neutrophils [#/volume] in Blood by Automated count

2086

14471

2.19

99.10

11.7

9.2

4.36

4.09

e9/l

5.70

1823

12542

(36304419) Bacteria [Presence] in Urine

1223

6899

2.22

98.90

3.8

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1766

11516

2.14

98.17

9.4

6.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

512

1949

2.92

96.21

2.4

2.5

64.86

67.07

g/l

7.65

470

1747

(3027945) Reticulocytes/100 erythrocytes in Blood

620

2612

2.69

96.01

2.4

1.88

1.67

5.99

561

2268

(3026250) Tacrolimus [Mass/volume] in Blood

11.32

92.93

35.8

32.3

7.82

7.55

ug/l

0.31

(3002582) Erythrocytes [#/volume] in Urine

1302

7804

2.10

87.61

4.0

3.1

77.40

92.32

e6/l

0.22

1015

5960

(3024928) Oxygen saturation in Venous blood

187

382

5.13

86.60

4.5

2.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1672

11021

2.04

86.34

6.1

4.6

34.25

35.62

g/l

17.40

1562

10177

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

620

2742

2.55

86.18

3.0

2.8

8.97

9.25

umol/l

0.14

560

2417

(3042733) HLA Ab [Presence] in Serum

13.37

85.44

4.5

—

(3042936) Bacteria identified in Isolate by Culture

703

3317

2.42

84.81

2.6

1.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

9.93

79.76

28.5

24.2

116.03

117.96

ug/l

0.08

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1290

7910

2.03

79.74

3.5

3.3

42.08

36.44

u/l

0.81

1224

7447

(3018095) Leukocytes [#/volume] in Urine

1413

8969

2.00

79.01

4.6

3.6

68.76

96.25

e6/l

1.33

1058

6349

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

359

1245

3.11

78.87

17.1

8.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1121

6597

2.06

77.08

3.6

2.5

1908.16

5287.16

umol/l

3.76

979

5750

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

828

4396

2.18

74.31

3.3

2.7

1.16

1.08

e6/l

0.21

467

2499

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

173

384

4.70

72.49

1.5

106.78

112.97

u/ml

0.49

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

362

1324

2.95

72.19

1.9

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2548

20179

2.13

72.16

11.5

7.3

82.43

78.90

u/l

2.29

2446

18892

(3003434) Protein [Mass/volume] in Pleural fluid

128

220

6.01

71.41

1.6

1.3

28.20

37.64

g/l

9.48

103

208

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

153

316

5.03

69.85

1.5

1.2

2.76

3.31

u/ml

0.45

130

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

783

4159

2.15

69.61

3.5

2.9

2.47

2.05

e6/l

0.68

422

2287

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

407

1616

2.73

69.47

1.7

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

188

461

4.26

69.41

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

188

461

4.26

69.41

1.4

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

184

444

4.33

69.37

10.0

5.3

233.67

4013.46

iu/ml

0.57

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

179

427

4.37

68.49

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

172

399

4.49

68.20

1.4

1.2

296.77

253.74

u/ml

1.03

126

243

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

515

2315

2.45

67.93

2.4

2.5

41.02

60.31

u/l

0.46

442

2017

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

153

329

4.83

66.59

1.5

1.2

1.71

2.66

u/ml

0.99

(3023199) Leukocytes [#/volume] in Pleural fluid

118

206

5.90

64.76

1.6

1.3

9511.87

2502.62

e6/l

0.37

148

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

175

436

4.18

63.21

1.4

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

235

721

3.43

62.80

2.3

2.1

0.01

0.05

g/l

1.03

211

662

(3023183) Ammonium ion [Moles/volume] in Plasma

184

478

4.02

62.80

2.4

3.0

32.60

37.66

umol/l

1.26

166

431

(3000850) Epithelial cells [#/volume] in Urine

916

5333

1.99

62.53

3.0

2.5

5.49

4.56

e6/l

1.46

827

4734

(3045788) Cell count panel - Pleural fluid

101

157

6.60

62.21

1.6

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

111

191

5.98

61.82

1.6

1.3

30753.25

85833.23

e6/l

1.11

111

(3023520) Reticulocytes [#/volume] in Blood

444

1942

2.48

61.81

2.5

74.07

66.43

e9/l

3.22

305

1464

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

220

656

3.52

61.43

2.3

2.2

0.00

g/l

-0.00

198

609

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

222

667

3.49

61.27

2.3

2.2

0.00

g/l

0.14

198

611

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

499

2327

2.35

60.13

2.2

2.3

0.20

0.22

g/l

3.36

467

2187

(3012441) Differential panel - Pleural fluid

107

183

6.01

59.96

1.5

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

223

701

3.34

57.27

3.1

52.28

119.33

mg/l

0.41

189

588

(3007853) Bacteria identified in Skin by Aerobe culture

544

2682

2.23

57.24

2.2

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

219

681

3.37

57.22

3.1

3.18

1.79

ratio

0.60

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

222

698

3.34

56.99

3.1

43.80

55.18

mg/l

0.43

188

586

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

109

201

5.57

56.45

2.5

2.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

130

281

4.77

56.19

8.9

6.4

10.56

11.55

mg/l

1.52

115

257

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

259

903

3.03

55.87

2.3

2.2

3.08

2.89

g/l

2.18

237

794

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

895

3.03

55.55

2.3

2.2

10.04

10.19

g/l

0.21

235

778

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

231

760

3.19

55.02

2.3

2.1

36.90

38.40

g/l

3.08

208

647

(3024471) HLA-A [Type]

9.72

54.87

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

484

2315

2.28

54.62

1.7

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

267

959

2.94

54.60

2.3

2.1

3.61

3.71

g/l

0.49

245

850

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

140

329

4.40

54.54

1.4

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

267

960

2.94

54.50

2.3

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

267

960

2.94

54.50

2.3

2.1

7.43

7.42

g/l

0.03

245

850

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

244

835

3.07

54.35

2.5

2.2

0.56

1.13

g/l

1.83

214

712

(3024932) HLA-DR beta [Type]

9.58

54.28

1.1

—

(3026782) Osmolality of Urine

862

5142

1.91

53.47

3.3

2.8

528.01

565.38

mosm/kgh2o

6.61

743

4367

(3048929) Epstein Barr virus Ab [Presence] in Serum

196

597

3.43

52.87

1.4

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

387

1709

2.43

52.35

4.9

3.5

126.41

81.13

ng/l

11.85

351

1484

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

104

197

5.42

52.31

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

375

1650

2.43

51.08

2.4

2.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

198

628

3.29

50.04

1.9

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2294

18467

1.78

49.57

4.6

3.6

15.25

14.79

pmol/l

12.81

2126

16509

(46235355) HIV 1 and 2 tests - Meaningful Use set

578

3081

2.06

49.11

1.9

1.6

—

(3019060) Gas panel - Arterial blood

335

1428

2.50

48.80

6.3

4.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

349

1519

2.45

48.59

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

110

235

4.81

48.21

5.7

2.9

—

(3044640) Blood type and Crossmatch panel - Blood

1183

7978

1.75

48.06

3.1

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

501

2551

2.14

48.00

1.8

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

102

211

4.96

46.44

3.2

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

166

495

3.48

46.24

1.6

—

(3051651) Icteric interference index of Serum or Plasma

132

6.11

45.32

6.6

3.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

948

6096

1.78

44.83

3.0

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2088

16613

1.69

44.41

5.3

4.2

1971.68

2201.54

e6/l

0.06

252

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

123

6.22

43.84

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

100

218

4.70

42.78

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

344

3.86

42.38

4.2

3.1

871.00

3916.92

u/ml

—

(40768806) Pleura Pathology biopsy report

194

4.90

41.93

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

163

514

3.28

41.54

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

478

2516

2.05

41.53

4.3

3.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

300

1309

2.42

41.34

1.6

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

541

2982

1.97

41.26

1.4

1.3

540.90

503.96

titre

0.14

111

611

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

176

591

3.09

40.38

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

158

498

3.28

40.29

3.1

3.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

163

525

3.21

40.11

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

167

5.13

40.04

1.4

1.3

6.72

5.67

mmol/l

1.50

149

(1616796) Gas panel - Central venous blood

148

455

3.36

39.28

5.7

2.9

—

(3026008) Bacteria identified in Urine by Culture

1054

7202

1.68

38.95

3.3

3.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

177

613

2.99

38.47

5.0

3.7

1.87

1.39

mg/l

9.47

162

571

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

102

246

4.25

38.42

1.1

—

(3034426) Prothrombin time (PT)

7.75

37.41

1.4

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

2598

22343

1.75

37.33

35.2

15.0

14.97

15.01

0.16

2566

21890

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

156

5.10

36.94

1.5

1.3

798.24

487.71

u/l

0.21

145

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

228

4.31

36.90

1.4

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

228

4.31

36.90

1.4

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

893

5915

1.70

36.71

1.8

1.5

19.47

20.31

nmol/l

0.96

802

4985

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

127

373

3.50

36.20

1.6

1.7

—

(3020891) Body temperature

217

868

2.60

35.87

7.5

4.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

120

342

3.60

35.80

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

120

342

3.60

35.80

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

139

436

3.28

35.72

3.6

2.3

16.34

16.83

0.57

228

(3009871) Measles virus Ab [Titer] in Serum

7.16

35.60

1.2

1.7

—

(3012501) Base excess in Blood by calculation

143

458

3.22

35.51

6.4

3.5

2.82

2.37

mmol/l

0.94

102

304

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

203

790

2.67

35.46

2.4

2.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

187

4.58

35.04

1.2

126.15

150.26

titre

0.19

(3010421) pH of Blood

158

550

2.97

34.02

6.4

3.4

7.42

0.84

141

485

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

133

420

3.26

33.81

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

293

1386

2.22

33.27

10.2

6.5

24.32

24.53

mmol/l

0.40

286

1316

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

162

579

2.89

33.26

1.6

1.5

0.23

0.24

g/l

0.75

150

546

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

374

3.38

33.23

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

165

599

2.85

32.91

1.6

1.4

1.14

1.21

g/l

1.58

155

561

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2884

25856

1.87

32.51

29.1

12.3

24.08

25.77

mg/l

2.28

2540

19953

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1533

11833

1.55

32.40

3.3

2.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1092

7816

1.59

32.12

3.1

2.5

59.40

60.90

u/l

0.44

1024

7176

(3036481) Cortisol [Moles/volume] in Serum or Plasma

382

2049

1.98

31.00

2.4

359.84

367.51

nmol/l

0.30

361

1881

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1415

10805

1.54

30.93

2.2

1.9

89.97

94.31

pmol/l

3.02

753

5601

(3018405) Lactate [Moles/volume] in Arterial blood

190

766

2.57

30.87

6.3

3.7

1.52

1.39

mmol/l

0.75

183

759

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

170

653

2.69

30.45

1.3

1.2

—

(3011648) Oxygen content in Venous blood

155

4.66

30.36

2.2

2.7

10.79

10.69

0.06

155

(3028026) IgM [Mass/volume] in Serum or Plasma

279

1354

2.16

29.64

2.1

1.9

1.42

1.46

g/l

0.07

258

1229

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

296

3.52

29.64

1.3

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2637

23237

1.65

29.23

5.7

4.3

2.05

2.13

mu/l

0.35

2462

20863

(3013707) Erythrocyte sedimentation rate by Westergren method

2239

19028

1.54

28.65

5.3

3.8

15.11

11.77

mm/h

16.82

2100

17450

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

209

920

2.36

28.06

2.2

1.9

1.34

2.51

ug/l

1.01

190

813

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

241

3.72

27.88

1.3

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

147

552

2.74

27.51

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

297

3.40

27.34

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

140

4.64

27.32

1.4

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

326

1748

1.96

26.32

3.0

2.6

10.00

10.50

g/l

1.33

306

1598

(3011397) Hemoglobin [Presence] in Urine by Test strip

823

5766

1.57

25.42

3.8

3.4

—

(3035880) pH of Pleural fluid

5.39

25.41

1.4

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.72

25.41

1.7

1.2

78.45

84.27

0.33

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

323

3.19

25.19

1.4

—

(3000492) Spirometry study

404

2355

1.81

25.14

1.6

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

290

3.31

24.86

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.68

24.53

1.6

1.2

79.84

76.30

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

135

516

2.68

24.43

1.4

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

353

2004

1.85

23.88

3.7

2.5

50.16

68.84

ml/min/173m2

15.84

150

742

(3006184) Hemoglobin [Mass/volume] in Capillary blood

130

498

2.68

23.43

2.9

1.9

130.69

131.28

g/l

0.08

339

(3007164) IgA [Mass/volume] in Serum or Plasma

643

4327

1.60

23.35

1.6

1.4

2.59

2.53

g/l

0.31

390

2556

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

9.71

23.22

1.3

1.1

78.60

139.00

ng/l

0.24

(3019550) Sodium [Moles/volume] in Serum or Plasma

2976

27488

1.79

23.05

38.5

13.7

139.27

139.72

mmol/l

16.59

2933

26670

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

135

4.28

22.07

1.6

1.2

15.63

14.77

u/l

0.04

129

(3037467) Urinalysis macro (dipstick) panel - Urine

2062

17656

1.44

22.02

5.0

4.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.51

21.95

2.2

2.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.22

21.91

1.3

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2978

27586

1.76

21.83

39.0

13.8

4.04

3.98

mmol/l

30.80

2932

26726

(3021901) Oxygen saturation in Capillary blood

105

378

2.84

21.33

4.2

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

114

4.53

21.25

1.2

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

114

4.53

21.25

1.2

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.93

20.88

1.3

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

205

3.52

20.86

1.9

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

256

3.22

20.65

3.4

4.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

268

1463

1.90

20.40

4.4

3.1

5.12

5.10

kpa

0.08

251

1380

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

257

1390

1.92

20.12

4.4

3.1

2.22

1.51

mmol/l

1.56

186

1003

(3015377) Calcium [Moles/volume] in Serum or Plasma

1127

8753

1.44

20.07

3.8

3.5

2.35

2.36

mmol/l

1.26

975

7621

(3019309) Folate [Moles/volume] in Red Blood Cells

686

4840

1.53

19.86

1.8

1.7

1204.27

1127.76

nmol/l

1.30

541

3583

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

247

3.21

19.83

1.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

227

3.31

19.81

1.5

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

171

804

2.19

19.62

6.7

1.5

4.87

4.68

mg/l

0.06

155

567

(3009343) pH of Capillary blood

262

1442

1.89

19.44

4.4

3.1

7.41

7.42

0.29

148

(3037756) Immunofixation for Serum or Plasma

113

457

2.52

18.30

1.6

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

672

4803

1.50

18.09

2.8

3.2

2.47

2.45

mmol/l

1.71

568

4231

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2727

24973

1.51

18.03

28.8

11.8

73.10

80.05

ml/min/173m2

43.91

2482

20255

(3012516) Albumin [Mass/volume] in Urine

1041

8097

1.42

17.92

3.6

3.2

265.17

300.71

mg/l

0.12

731

5115

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

365

2.68

17.62

5.1

2.6

—

(3009508) Creatinine [Moles/volume] in Urine

1078

8460

1.41

17.54

3.5

3.1

7.08

7.94

mmol/l

9.33

918

7111

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

115

481

2.44

17.35

1.4

1.8

3.44

4.75

iu/l

0.76

157

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

213

3.19

16.97

1.1

1.2

64.23

62.76

u/l

0.03

193

(3020682) Albumin/Creatinine [Ratio] in Urine

1078

8524

1.39

16.56

4.0

3.7

15.30

5.96

mg/mmol

5.34

729

5366

(3025941) Bacteria identified in Stool by Culture

219

1201

1.88

16.42

1.4

1.2

—

(3003181) Sodium [Moles/volume] in Urine

397

2.54

16.35

1.5

1.4

61.07

64.61

mmol/l

0.33

323

(42529406) Shigella sp [Presence] in Stool by Culture

142

669

2.17

16.25

1.3

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

134

618

2.22

16.16

1.2

1.3

194.29

84.17

titre

0.58

(3014765) Yersinia sp identified in Stool by Organism specific culture

141

664

2.17

16.15

1.3

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.21

15.31

1.4

1.3

61.23

58.71

0.11

(3021788) Differential panel - Synovial fluid

101

422

2.44

15.31

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

138

661

2.13

15.16

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

345

2.56

14.73

1.2

—

(3013512) EKG study

933

7327

1.38

14.55

6.1

3.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2664

24554

1.43

14.51

6.7

5.7

41.44

39.89

mmol/mol

12.17

2513

22491

(3001893) Eosinophils/100 leukocytes in Pleural fluid

5.55

14.29

1.4

1.2

2.62

2.65

0.01

(3023419) Bacteria identified in Sputum by Culture

345

2.53

14.23

2.1

2.6

—

(40761511) CBC panel - Blood by Automated count

2898

27178

1.52

14.13

24.5

11.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

190

3.09

14.03

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

190

3.09

14.03

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

190

3.09

14.03

1.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1234

10169

1.34

13.97

2.6

2.1

76.41

78.45

nmol/l

1.61

1117

8968

(3033799) Differential panel - Peritoneal fluid

4.61

13.75

2.4

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

322

2069

1.62

13.74

5.8

3.5

1.21

1.23

mmol/l

6.48

301

1776

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

289

2.63

13.49

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

397

2.38

13.48

1.9

2.0

4.94

5.11

mmol/24h

0.20

341

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

397

2.38

13.48

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

321

2.53

13.26

1.3

0.39

0.35

nmol/l

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

358

2.44

13.18

1.5

1.6

0.57

0.86

g/l

2.35

280

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

328

2.51

13.17

1.2

—

(3042631) Mycobacterium sp identified in Specimen

331

2.48

12.93

1.8

2.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1447

12302

1.31

12.81

4.1

3.4

0.00

estimate

1.54

313

2440

(3021601) Nitrite [Presence] in Urine by Test strip

1446

12320

1.31

12.49

5.5

4.6

0.00

estimate

0.50

297

2273

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

382

2.34

12.32

1.1

1.3

31.93

34.57

u/l

0.08

319

(3004451) EKG impression Narrative

3.98

12.17

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.69

11.88

1.9

1.3

17.35

11.29

g/l

2.60

(3000093) Morphology [Interpretation] in Blood Narrative

215

2.78

11.86

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.25

11.72

2.3

1.8

27586.05

2910.67

e6/l

0.60

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

193

2.83

11.27

1.1

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.56

11.16

4.1

6.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1449

12471

1.29

11.16

4.1

3.4

0.00

0.01

estimate

1.57

280

2195

(3024139) IgG subclass 3 [Mass/volume] in Serum

211

2.73

11.14

1.4

1.3

0.47

0.39

g/l

0.86

151

(3028192) IgG subclass 2 [Mass/volume] in Serum

211

2.73

11.14

1.4

1.3

2.89

3.04

g/l

0.19

154

(3027135) IgG subclass 1 [Mass/volume] in Serum

211

2.73

11.14

1.4

1.3

7.93

6.45

g/l

1.28

155

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.27

11.05

4.1

6.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1853

16475

1.28

10.92

3.8

3.0

72.14

50.12

u/l

11.34

1722

15154

(3000494) Fungus identified in Specimen by Culture

412

2943

1.46

10.71

1.8

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

126

665

1.93

10.68

1.3

—

(3000012) Reticulocyte production index

307

2.38

10.54

2.2

2.0

—

(4062490) Immunoglobulin typing, IgG

212

2.67

10.50

1.5

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

10.42

2.0

0.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1617

14192

1.27

10.34

2.8

2.6

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

12.06

10.33

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.72

10.13

2.7

2.0

591.61

482.39

e6/l

0.36

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

166

2.86

10.06

1.8

1.0

—

(3015736) pH of Urine

1161

9810

1.28

10.03

3.8

3.2

5.71

5.78

0.22

671

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

109

3.33

9.98

1.1

1.2

1.06

1.07

ratio

0.07

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

163

2.85

9.79

2.1

2.3

—

(40768797) Stomach Pathology biopsy report

469

3491

1.40

9.67

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

170

1016

1.71

9.62

1.3

—

(3003338) MCHC [Mass/volume]

2381

22003

1.29

9.59

39.5

16.2

330.01

333.19

g/l

50.81

2358

21818

(3016650) Hepatitis A virus Ab [Presence] in Serum

362

2.18

9.40

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

276

2.34

9.18

1.2

1.3

—

nmol/l

—

(3047189) Immunofixation for 24 hour Urine

100

3.32

9.16

1.7

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.42

9.07

1.0

1.1

—

(3014891) Appearance of Pleural fluid

11.48

9.05

1.4

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

116

632

1.87

8.99

2.1

2.2

105.68

99.54

ug/min

0.08

384

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

194

2.60

8.98

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.09

8.97

1.2

60.15

85.13

2.36

(3003327) Ova and parasites identified in Stool by Light microscopy

124

691

1.83

8.94

1.5

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

139

802

1.77

8.93

1.3

1.2

0.45

0.76

u/ml

0.30

(3017569) Oxygen content in Arterial blood

107

3.20

8.89

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

120

2070

0.56

8.77

1.6

1.8

—

(1761868) Lipid panel - Serum or Plasma

737

8974

0.77

8.67

3.2

2.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

451

2.00

8.55

3.8

3.6

60.45

56.92

1.69

451

(3044007) Cell count panel - Peritoneal fluid

3.81

8.50

2.7

1.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

126

2.96

8.49

1.7

1.5

2.78

7.15

u/l

1.89

107

(21494755) Public health laboratory ask at order entry panel

123

2080

0.58

8.36

1.2

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

4.47

8.36

1.8

1.2

21.36

23.89

0.14

(3020876) Protein [Mass/time] in 24 hour Urine

227

2.40

8.24

2.7

2.3

2.08

1.35

g/24h

0.53

108

(3017181) Myelocytes/100 leukocytes in Blood

302

2141

1.45

8.14

5.3

4.2

0.71

1.00

2.20

126

723

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

617

4918

1.31

8.05

1.2

2.20

1.89

u/ml

0.13

150

1256

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

158

2.68

8.05

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

158

2.68

8.05

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

158

2.68

8.05

1.3

1.1

—

(40761536) Microorganisms panel - Urine sediment

289

2036

1.46

8.05

4.6

3.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

22.07

8.01

2.9

4.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.85

7.96

1.2

1.3

55.15

89.00

2.54

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.53

7.96

4.4

1.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

396

2.02

7.86

1.3

1.2

51.83

31.98

u/ml

—

(4035726) Immunohistochemistry procedure

339

2472

1.41

7.83

2.1

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

161

2.63

7.77

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

161

2.63

7.77

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

161

2.63

7.77

1.3

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.66

7.73

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.91

7.67

4.2

5.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

386

2891

1.38

7.61

1.7

1.8

1.61

1.52

1.13

323

2540

(44816559) Phosphatidylethanol [Mass/volume] in Blood

429

1.96

7.58

1.2

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

7.11

7.47

1.3

1.0

90.53

102.54

0.52

(40761535) Cells panel - Urine sediment

291

2086

1.43

7.40

4.0

3.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

178

2.49

7.32

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

478

1.89

7.28

1.2

1.3

264.94

215.75

miu/ml

0.42

199

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

381

1.99

7.22

1.2

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.49

7.17

1.3

1.0

1.45

2.30

mmol/l

1.46

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.19

7.11

1.2

1.1

293.81

202.99

iu/ml

0.31

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

243

3406

0.69

7.07

4.7

4.6

32.18

32.14

0.02

190

2174

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.98

6.99

1.3

19.00

8.07

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2630

24910

1.27

6.96

4.6

3.9

1.40

1.32

mmol/l

6.15

2447

22430

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

260

2.17

6.85

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

172

2.46

6.84

1.9

2.3

13.95

15.41

0.36

165

(3002179) Metamyelocytes/100 leukocytes in Blood

271

1947

1.43

6.81

5.2

4.0

0.59

0.72

0.42

104

613

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.64

6.74

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

150

2.55

6.68

1.3

1.4

—

(3028433) Virus identified in Specimen by Culture

3.11

6.58

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

3.11

6.58

14.7

4.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.82

6.53

1.7

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

150

963

1.58

6.51

6.2

4.9

1.68

1.60

0.51

145

902

(3021440) Promyelocytes/100 leukocytes in Blood

280

2043

1.40

6.46

5.4

4.2

0.07

0.14

1.47

104

629

(3044941) Cell count panel - Synovial fluid

383

1.93

6.44

1.3

1.4

—

(3022313) Gas panel - Capillary blood

165

1086

1.55

6.43

4.5

3.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1334

0.54

6.37

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

136

2.59

6.36

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

136

2.59

6.36

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

107

634

1.71

6.36

2.3

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

399

1.90

6.36

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

399

1.90

6.36

1.9

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

103

605

1.72

6.32

1.5

1.6

11511.20

12490.80

e6/l

0.15

422

(3011412) CD3 cells [#/volume] in Blood

217

2.23

6.29

2.5

2.6

0.95

1.21

e9/l

1.63

194

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

137

2.57

6.28

2.4

3.0

43.11

37.93

0.66

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.85

6.25

1.0

1.3

0.85

0.66

umol/24h

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

150

2.48

6.18

1.6

1.4

6.13

6.44

u/l

0.14

123

(3025159) Blasts/100 leukocytes in Blood

265

1932

1.40

6.15

5.5

4.2

0.72

0.37

0.20

510

(21494434) Karyotype in Bone marrow

200

2.27

6.14

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

146

953

1.56

5.92

6.3

4.9

0.82

0.89

1.63

141

893

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.02

5.83

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.24

5.72

1.3

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

486

3930

1.28

5.57

1.3

1.2

31.19

38.91

iu/ml

0.73

153

1229

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

113

706

1.62

5.54

1.4

1.6

0.08

4.58

iu/ml

0.51

138

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2921

28206

1.29

5.46

16.5

9.9

28.00

26.94

u/l

1.52

2835

27017

(3000570) Elastase.pancreatic [Mass/mass] in Stool

117

741

1.60

5.43

1.2

1.4

328.08

269.16

ug/g

0.53

419

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

118

2.56

5.37

1.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

200

2.17

5.31

2.1

2.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.11

5.28

2.4

3.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

2.30

5.27

1.2

1.1

—

(4200892) Spirometry reversibility

238

1752

1.39

5.25

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

5.40

5.22

1.4

1.0

0.55

3.68

mmol/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

105

655

1.62

5.20

1.6

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

3.23

5.16

1.2

1.0

—

(3019977) pH of Arterial blood

110

2.56

5.04

2.6

7.41

7.42

0.32

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.77

5.03

2.0

2.5

25.83

28.86

0.45

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

141

957

1.49

4.84

4.5

3.2

24.53

24.68

mmol/l

0.21

132

881

(3006245) CD3-CD19+ cells/100 cells in Blood

2.71

4.84

2.2

2.6

10.46

11.97

0.14

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.89

4.76

2.0

—

(3003694) ABO and Rh group [Type] in Blood

793

6872

1.20

4.72

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

287

1.90

4.69

1.4

1.5

64.40

56.86

0.65

176

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

103

2.54

4.62

2.3

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.13

4.60

1.5

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.91

4.60

1.2

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

153

2.23

4.59

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

128

2.36

4.57

2.8

2.1

120.33

233.82

ug/min

—

(3047181) Lactate [Moles/volume] in Blood

110

718

1.55

4.55

7.2

5.9

1.35

1.29

mmol/l

0.33

103

635

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.56

4.54

1.2

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

344

2736

1.29

4.50

2.0

2.3

148.76

158.99

ug/g

0.17

280

2160

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

148

2.24

4.50

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

148

2.24

4.50

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.68

4.46

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

453

3735

1.25

4.38

1.2

13.05

13.88

u/ml

0.08

157

1412

(3049717) Cytology report of Urine Cyto stain

155

1097

1.43

4.33

2.5

2.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

166

1191

1.41

4.30

1.5

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

246

1.92

4.30

12.1

7.5

7.13

7.51

mmol/l

0.37

195

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.15

4.20

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

140

979

1.45

4.18

2.1

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

328

1.78

4.18

1.2

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

6.94

4.16

1.0

17.57

23.55

g/l

—

(3045414) Leukocytes [Presence] in Urine

158

1131

1.42

4.16

2.1

1.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

115

2.36

4.15

1.3

1.2

244.74

472.84

u/l

0.87

110

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

235

1.93

4.15

1.3

1.2

1.87

1.41

nmol/l

1.46

209

(3022145) Colonoscopy Study observation

359

2901

1.27

4.14

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

154

2.15

4.11

2.6

2.7

422.84

596.88

e6/l

1.14

128

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

123

842

1.48

4.10

1.7

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

110

2.37

4.06

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.51

4.04

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2685

25870

1.20

4.01

5.0

4.3

1.33

1.45

mmol/l

44.52

2513

23511

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2764

26705

1.21

3.99

5.8

4.9

2.49

2.78

mmol/l

51.27

2597

24308

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.68

3.98

1.6

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

573

1.57

3.95

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2705

26090

1.20

3.94

5.1

4.4

4.29

4.68

mmol/l

67.43

2543

23877

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

292

1.79

3.86

1.1

—

(4034850) Laboratory test

121

837

1.46

3.85

17.5

8.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

696

0.53

3.81

1.8

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

120

2.26

3.80

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

180

1340

1.36

3.78

1.4

1.3

248.92

259.40

u/ml

0.06

172

1228

(3036525) Urea [Moles/time] in 24 hour Urine

8.77

3.77

3.0

3.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

12.02

3.76

1.2

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

115

2.27

3.70

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

115

2.27

3.70

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

168

2.03

3.69

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.12

3.65

1.7

1.9

—

(3037121) Protein [Mass/volume] in Urine

118

823

1.45

3.62

2.8

3.5

0.33

0.27

g/l

0.35

358

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.40

3.55

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.40

3.55

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.01

3.49

3.2

6.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.01

3.49

3.3

7.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

10.01

3.49

2.5

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.71

3.48

1.6

1.5

9.95

8.60

ug/l

0.44

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

875

9729

0.86

3.41

3.6

4.4

23.17

21.66

1.68

369

4948

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.08

3.39

1.5

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

203

1567

1.31

3.37

1.3

26.50

64.12

au/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.03

3.25

1.3

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

301

1.71

3.25

1.1

1.3

343.32

275.59

pmol/l

0.64

260

(3002256) Pathology report gross observation

414

3492

1.21

3.24

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

2.58

3.21

2.0

2.3

162.50

562.14

e6/l

0.50

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

140

1033

1.37

3.16

2.4

3.8

458.98

2613.21

u/ml

1.08

115

894

(36660697) Celiac disease serology panel - Serum

224

1769

1.29

3.16

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

180

1381

1.32

3.14

1.6

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

396

3338

1.21

3.12

1.5

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

305

1.68

3.11

1.1

—

(3011985) Renin [Units/volume] in Plasma

321

1.66

3.08

1.3

1.4

70.93

62.55

mu/l

0.09

294

(3008295) Osmolality of Serum or Plasma

253

1.75

3.08

1.7

1.4

276.24

281.29

mosm/kgh2o

0.71

195

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

2.15

3.06

3.0

4.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

200

0.30

3.05

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

7.51

3.05

1.2

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

139

2.02

3.05

1.1

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

125

913

1.38

3.02

1.8

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1008

0.66

2.95

1.8

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2661

25789

1.16

2.93

5.2

4.6

6.22

5.99

mmol/l

13.28

2450

23267

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.45

2.89

1.4

1.7

—

(40768443) Skin Pathology biopsy report

148

1120

1.34

2.87

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

544

1.48

2.86

1.3

1.2

5.36

8.64

u/ml

0.48

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

537

1.48

2.83

1.3

1.2

7.43

2.18

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.20

2.83

1.1

1.3

148.95

179.59

mmol/24h

0.99

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

145

1097

1.34

2.82

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.92

2.77

1.0

1.5

2.19

1.77

umol/24h

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

166

1.88

2.76

1.2

1.3

—

86.67

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

8.34

2.75

1.0

282.40

309.83

nmol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

301

1.64

2.74

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

1143

10553

1.13

2.70

2.2

2.1

—

(40768446) Kidney Pathology biopsy report

2.24

2.70

2.2

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

175

1.84

2.68

2.5

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

197

1.78

2.67

1.6

1.5

45.80

25.35

u/ml

—

(3045142) Bone marrow Pathology biopsy report

296

1.63

2.65

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

192

1525

1.27

2.63

1.7

1.9

—

(3014271) Vancomycin [Susceptibility]

113

2.04

2.61

4.3

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

313

1.61

2.61

1.6

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

168

1314

1.29

2.60

1.1

1.2

202.35

142.88

iu/ml

0.65

466

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.34

2.60

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

557

1.45

2.57

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

107

2.06

2.57

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.15

2.55

1.0

1.7

—

(3044927) Protein electrophoresis panel - Urine

239

1.68

2.51

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

213

1725

1.25

2.50

2.4

13.79

24.28

au/ml

—

120

(3029937) Albumin [Presence] in Urine by Test strip

736

6650

1.14

2.43

4.8

3.7

0.01

0.00

estimate

0.23

279

2207

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.09

2.42

1.8

3.0

47.10

172.89

umol/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

2987

29302

1.19

2.42

43.2

18.4

39.85

40.79

3.36

2852

27198

(21494814) CD8 cells/100 lymphocytes in Specimen

2.12

2.38

1.8

2.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

3.64

2.36

2.9

5.4

84.25

50.29

ug/min

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

137

1757

0.77

2.35

1.5

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

236

1.66

2.35

1.2

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

118

1.96

2.35

1.4

4.00

4.04

0.01

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

229

1.67

2.33

1.4

24.54

30.16

0.44

134

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

237

1.65

2.32

1.2

—

(3000330) Specific gravity of Urine by Test strip

164

1303

1.27

2.28

3.6

3.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.76

2.27

1.6

3.4

—

(3007461) Platelets [#/volume] in Blood

2986

29316

1.18

2.26

41.8

18.4

233.54

247.37

e9/l

23.17

2926

28374

(3035941) MCH [Entitic mass]

2987

29329

1.18

2.24

41.6

18.3

30.51

30.44

1.20

2945

28786

(3024731) MCV [Entitic volume]

2987

29331

1.18

2.23

41.6

18.3

92.23

91.19

26.42

2946

28788

(3000963) Hemoglobin [Mass/volume] in Blood

2988

29342

1.18

2.23

42.0

18.4

132.68

137.07

g/l

41.08

2949

28801

(3026361) Erythrocytes [#/volume] in Blood

2987

29333

1.18

2.22

41.8

18.3

4.39

4.53

e12/l

34.62

2925

28274

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

303

1.56

2.22

3.1

3.4

5.00

22.53

nmol/l

0.48

296

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

166

1329

1.26

2.18

2.6

2.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

122

1.89

2.16

1.3

1.5

—

(3010813) Leukocytes [#/volume] in Blood

2986

29332

1.18

2.16

41.8

18.4

7.05

6.70

e9/l

10.71

2921

28270

(3024263) Appearance of Synovial fluid

137

1.83

2.13

1.3

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

175

1.72

2.09

1.2

1.3

905.00

490.77

titre

—

(3042517) Benzodiazepines panel - Urine

5.01

2.07

2.4

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.01

2.07

1.6

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.91

2.07

5.1

6.4

—

(3025130) Human papilloma virus identified in Specimen

191

1.68

2.06

1.9

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

778

7130

1.12

2.02

1.6

1.45

1.38

mmol/l

1.22

650

5983

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.50

2.01

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.50

2.01

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.82

2.00

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

2.08

1.96

1.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.55

1.94

2.4

1.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.97

1.93

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.97

1.93

1.5

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.97

1.93

1.5

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.75

1.93

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.19

1.88

1.1

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.19

1.88

1.1

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

114

1.85

1.87

6.2

2.6

13.22

20.09

mu/l

1.78

109

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.86

1.86

1.3

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.98

1.84

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

115

1.83

1.82

3.8

3.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.17

1.82

1.2

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1129

12000

0.91

1.82

4.2

5.1

2.50

3.48

ug/l

1.60

986

10814

(40768795) Lymph node Pathology biopsy report

262

1.53

1.81

1.1

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.05

1.80

1.0

—

(3017704) Immunofixation for Urine

123

1.79

1.6

1.5

—

(40768441) Liver Pathology biopsy report

176

1.65

1.79

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.17

1.77

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

169

1.66

1.77

2.0

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

485

0.64

1.76

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

193

1.61

1.74

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

225

1.56

1.73

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.67

1.72

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

316

1.46

1.68

1.9

2.1

—

4.25

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

215

2522

0.84

1.67

2.2

2.1

12.52

13.06

nmol/l

0.45

187

2267

(3006442) Creatine [Moles/volume] in Serum or Plasma

172

1.63

1.67

1.6

1.4

85.54

82.90

umol/l

0.14

172

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.50

1.66

1.4

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

251

0.52

1.62

1.0

32.87

44.42

ng/l

—

159

(3033705) Calcium.ionized [Moles/volume] in Venous blood

286

1.47

1.62

2.5

1.9

—

(3004775) Volume in Urine collected for unspecified duration

206

1.56

1.59

2.0

2.2

635.38

634.94

0.00

134

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

136

1.70

1.58

2.3

1.6

1.38

3.21

u/field

0.69

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

136

1.70

1.58

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

365

1.40

1.53

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

1.70

1.52

1.2

1.1

1.04

1.17

u/l

0.78

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.16

1.50

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

108

1.76

1.50

1.0

1.1

86.19

86.71

u/l

0.01

102

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

109

1.75

1.46

1.0

1.1

21.15

29.89

u/l

0.40

102

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.73

1.43

4.8

2.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

329

2929

1.14

1.41

2.9

4.6

7.40

24.61

ug/l

2.78

268

2426

(40757373) Influenza virus identified in Isolate

2.18

1.40

1.4

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.42

1.39

1.0

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.08

1.38

1.1

—

(3016750) Collection duration of Urine

142

1.62

1.38

2.0

489.88

492.93

min

0.05

108

(3019420) Tryptase [Mass/volume] in Serum or Plasma

119

1.68

1.37

1.2

1.4

6.71

6.90

ug/l

0.03

107

(3011048) Pyruvate [Moles/volume] in Blood

2.94

1.36

1.4

1.2

108.00

91.71

umol/l

—

(40768800) Prostate Pathology biopsy report

843

0.77

1.33

1.2

—

(3048879) Bone marrow aspiration report

1.92

1.33

2.3

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

2.10

1.30

1.4

—

(3002619) Bacteria identified in Specimen by Culture

2.10

1.30

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.78

1.28

2.2

3.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.40

1.24

1.0

1.1

0.05

0.77

u/ml

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.97

1.22

1.4

1.2

3.09

1137.68

ug/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

156

1.54

1.20

1.3

3.39

1.12

u/ml

0.50

(3008757) Leukocyte morphology finding [Identifier] in Blood

281

1.39

1.18

4.3

4.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

525

1.28

1.17

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.15

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

174

1.50

1.15

1.5

1.02

0.97

g/l

0.35

174

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.00

1.12

1.5

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.96

1.11

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.78

1.10

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.26

1.10

3.1

1.5

133.71

151.54

ng/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

201

1.45

1.09

1.3

1.5

0.21

0.26

nmol/l

0.42

165

(3020191) Ethanol [Moles/volume] in Serum or Plasma

202

1.44

1.07

1.4

1.07

1.18

promille

0.18

157

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

330

1.34

1.07

1.9

2.2

859.11

2298.10

u/l

0.61

117

(3036071) Salmonella sp Ab [Titer] in Serum

1.76

1.06

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

650

1.24

1.06

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

418

1.30

1.06

3.2

3.5

1.21

1.45

0.24

360

(3005011) Chlamydia sp Ab [Titer] in Serum

2.12

1.05

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

138

1.53

1.02

1.1

1.4

1.48

1.55

g/l

0.75

138

(3022621) pH of Urine by Test strip

186

1635

1.15

1.02

3.0

2.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.62

0.99

1.1

0.40

1.07

u/ml

—

(4146454) Self-monitoring of blood glucose

332

0.69

0.98

2.9

2.8

—

(3032057) Clostridioides difficile [Presence] in Stool

1.84

0.98

1.9

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

158

0.57

0.98

20.2

18.7

1378.56

1359.84

nmol/l

—

153

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.18

0.98

1.6

1.9

63.40

47.52

umol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.18

0.98

2.0

2.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

648

1.22

0.98

1.6

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

2.22

0.93

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

209

1.39

0.92

2.3

2.0

0.77

2.00

u/field

1.26

(44813793) Dust mix specific IgE antibody measurement

143

1.47

0.89

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

143

1.47

0.89

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

153

0.59

0.88

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

153

0.59

0.88

1.2

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

280

1.33

0.88

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

154

0.58

0.88

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

154

0.58

0.88

1.2

1.4

—

(3036180) Methadone [Presence] in Urine

1.63

0.84

1.8

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

524

1.23

0.83

1.5

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

222

1.35

0.83

1.2

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

138

0.58

0.83

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

146

1.44

0.82

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.69

0.82

1.1

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.82

0.79

2.8

2.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.82

0.79

1.8

2.1

19.32

19.83

umol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

156

1.41

0.78

1.0

1.1

0.09

8.19

nmol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

162

0.62

0.76

1.2

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

677

1.19

0.76

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

174

1.38

0.76

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.77

0.76

1.2

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

288

1.29

0.75

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.84

0.73

1.1

9.04

9.26

mg/g

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

167

1.38

0.73

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

150

1.40

0.73

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

254

0.71

0.73

1.3

177.19

207.60

pmol/l

0.32

254

(3015183) Erythrocyte sedimentation rate

108

0.55

0.72

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.58

0.71

1.7

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

152

1.38

0.69

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

188

1.33

0.66

4.4

5.4

34.90

45.91

u/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

568

1.18

0.65

2.2

1.7

358.20

303.52

mu/l

0.48

526

(3047352) Trisomy 18 risk [Likelihood] in Fetus

127

0.63

0.64

1.1

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

127

0.63

0.64

1.1

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.67

0.61

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.46

0.61

1.1

0.58

1.10

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

574

1.17

0.59

1.4

11.56

8.89

u/l

0.72

474

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.50

0.59

1.0

1.1

1195.50

1652.85

miu/ml

0.93

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

263

1.26

0.59

1.1

—

3.21

—

(40768793) Breast Pathology biopsy report

509

0.82

0.59

1.1

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

106

1.42

0.57

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

106

1.42

0.57

1.3

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

132

1.37

0.57

6.0

7.0

—

(4281824) Cell count and differential, peritoneal fluid

238

1.26

0.56

1.5

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

107

1.40

0.55

2.0

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

1.36

0.55

1.7

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

194

0.72

0.54

1.1

—

54.35

—

(3005033) Fetal Nuchal fold Thickness US

126

0.63

0.54

1.1

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.48

0.53

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.48

0.53

1.0

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.54

0.53

1.2

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

260

0.77

0.52

2.9

3.1

40.91

28.47

mg/l

0.29

195

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

685

7104

0.95

0.50

2.7

3.1

0.84

0.78

ug/l

0.41

487

4799

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

108

0.65

0.48

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

662

1.14

0.48

1.4

29.35

29.59

iu/l

0.02

561

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

189

0.74

0.48

1.1

—

78.50

—

(3017732) Neutrophils [#/volume] in Blood

159

1724

0.92

0.47

3.1

3.2

6.99

5.31

e9/l

0.39

129

1349

(3024869) Neuronal Ab [Presence] in Serum

1.49

0.47

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.47

0.47

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.47

0.47

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.47

0.47

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.47

0.47

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

374

1.18

0.46

1.9

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

273

1.21

0.46

3.1

3.5

66.27

55.52

2.39

216

(3023410) Appearance of Cerebral spinal fluid

255

1.22

0.45

1.3

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.59

0.45

1.4

2.3

64.60

151.06

nmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

175

0.74

0.44

1.8

1.4

—

(3019225) pH of Specimen

252

2671

0.94

0.43

5.2

4.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

122

1.31

0.42

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.40

0.42

1.6

2.9

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.14

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

1.27

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

3.79

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

325

1.17

0.39

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

261

1.19

0.38

4.5

2.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

695

0.89

0.38

4.8

4.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.32

0.37

1.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

107

1.31

0.37

1.2

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

225

1.20

0.37

1.1

1.3

—

(3016879) Cocaine [Presence] in Urine

563

1.12

0.36

3.5

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.66

0.35

1.8

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.64

0.35

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

201

0.80

0.35

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

461

1.13

0.34

3.4

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

573

0.89

0.33

4.2

3.2

31.42

27.61

mg/l

0.31

339

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

348

3341

1.05

0.33

16.4

5.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

237

1.18

0.33

1.3

261700.25

121958.99

e6/l

0.23

162

(3045424) Erythrocytes [Presence] in Urine

456

0.88

0.33

1.6

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

1.30

0.33

8.5

7.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.35

0.32

1.6

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.33

0.32

1.2

35.22

40.04

g/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

756

0.91

0.30

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.30

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.27

0.30

1.1

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

278

1.15

0.29

1.1

0.48

1.74

u/ml

2.13

143

(3025468) Yersinia sp identified in Specimen by Organism specific culture

316

1.14

0.29

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

316

1.14

0.29

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.23

0.29

1.4

1.0

15.40

16.20

umol/l

—

(3000764) Benzodiazepines [Presence] in Urine

603

1.10

0.28

3.4

2.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

1.25

0.28

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.29

0.28

2.9

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.29

0.28

2.9

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

242

1.16

0.28

1.1

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

261

1.15

0.27

1.0

1.1

—

18.58

—

(3011288) Drugs identified in Urine by Screen method

384

1.12

0.27

7.7

3.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

318

1.13

0.27

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

967

9497

1.03

0.27

4.6

3.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

319

1.13

0.26

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.68

0.26

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.68

0.26

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

245

2550

0.96

0.25

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

1.21

0.25

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

110

1033

1.07

0.25

3.2

3.6

81.59

61.12

u/ml

0.39

105

998

(3027008) Opiates [Presence] in Urine

609

1.09

0.24

3.4

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

257

2666

0.96

0.24

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

600

1.08

0.24

3.5

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

286

0.87

0.23

1.2

1.1

3.01

2.22

u/ml

0.21

119

(3008898) HLA-B27 [Presence]

713

0.92

0.23

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

611

1.08

0.23

3.5

1.9

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.25

0.22

1.4

3.0

1.15

1.19

mmol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

7.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.39

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.98

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

135

1.19

0.21

1.4

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

135

1.19

0.21

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

648

6606

0.98

0.21

4.0

3.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

335

1.11

0.20

1.8

1.7

16.00

23.24

mg/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.20

0.0

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.22

0.20

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

0.80

0.20

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

0.83

0.19

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

1.19

0.19

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.24

0.18

1.3

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.19

0.18

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

119

1.18

0.17

1.9

1.2

68.80

64.67

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.71

0.16

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.79

0.15

2.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

543

0.94

0.14

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

587

1.06

0.14

1.4

1.5

1255.22

596.96

e6/l

0.26

481

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

588

1.06

0.13

1.4

101.21

15.17

e6/l

0.48

459

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

228

1.10

0.13

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.17

0.13

1.1

—

4.66

—

(3006462) Nitrate [Presence] in Urine

117

0.85

0.13

1.4

3.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

277

1.08

0.12

1.0

1.1

—

0.73

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

104

1.15

0.12

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

680

0.96

0.11

1.4

1.3

652.63

539.70

mg/l

1.01

647

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

198

0.91

0.10

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

241

1.08

0.10

1.1

1.0

5.10

2.33

u/ml

0.37

113

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

319

1.07

0.10

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.14

0.10

1.6

3.3

1.13

1.18

mmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

310

1.07

0.09

1.1

7.42

5.10

u/ml

0.36

159

(3004616) Nuclear Ab [Presence] in Serum

279

0.93

0.09

1.3

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

0.88

0.08

1.2

—

(3019150) Specific gravity of Urine by Refractometry

534

5393

0.99

0.08

5.2

3.8

1.02

kg/l

0.81

838

(3023430) Cat dander IgE Ab [Units/volume] in Serum

225

1.07

0.07

1.1

1.0

3.05

4.22

u/ml

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

639

1.03

0.07

1.6

1.8

201.34

212.49

pmol/l

0.40

607

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

551

1.04

0.06

2.3

1.7

1.13

0.78

nmol/l

2.30

463

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

216

1.07

0.06

1.1

1.3

2.33

1.99

mmol/l

0.50

206

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

105

0.86

0.06

1.1

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

164

1616

1.02

0.05

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

555

5587

0.99

0.05

1.8

1.7

445.63

28794866.57

pmol/l

4.17

452

4612

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

356

1.04

0.05

1.1

0.19

1.66

u/ml

4.19

193

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

111

1.08

0.04

2.2

1.5

26.75

29.00

umol/l

0.46

105

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

190

1.05

0.04

1.1

1.0

0.29

0.49

u/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

1.07

0.03

1.0

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

589

1.02

0.02

2.5

3.7

994.59

858.67

u/ml

0.06

539

(3005570) Glucose [Moles/volume] in Urine

239

0.96

0.02

1.5

1.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

148

0.95

0.02

1.1

1.3

1.14

1.15

nmol/l

—

112

(1002224) Polysomnography panel

971

1.01

0.01

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

303

1.02

0.01

1.0

1.1

2.00

1.89

u/ml

0.03

137

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

256

0.98

0.00

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

316

0.98

0.00

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

315

0.98

0.00

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

535

0.99

0.00

1.4

—

(3003129) Base excess in Capillary blood by calculation

0.88

0.00

2.6

1.4

-1.88

0.54

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.88

0.00

1.4

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.52

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.4

—

4.19

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1933.00

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.91

-0.00

5.8

3.0

—

(3007733) Chloride [Moles/volume] in Urine

0.00

-0.00

0.0

1.5

—

60.33

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

110

1.00

-0.00

1.5

1.3

23.92

28.21

umol/l

0.19

103

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1270.00

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.91

-0.00

2.0

2.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

-0.00

0.0

2.7

—

0.08

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

3.30

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDMYOOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CARDMYOOTH	2.542 [2.24, 2.88]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.101

During the follow-up period (1.1.1998 — 31.12.2019), 1540 out of 5408 females with I9_CARDMYOOTH died.

Males

Parameter	HR [95% CI]	p-value
I9_CARDMYOOTH	2.934 [2.64, 3.26]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.034

During the follow-up period (1.1.1998 — 31.12.2019), 3551 out of 8905 males with I9_CARDMYOOTH died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDMYOOTH.

N-year risk	Females	Males
1	0.194%	0.628%
5	1.26%	3.754%
10	3.269%	9.214%
15	6.251%	17.151%
20	11.13%	27.492%

Relationships between endpoints

↥

Index endpoint: I9_CARDMYOOTH – Cardiomyopathy, other and unspecified

GWS hits: 9

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiomyopathy, other and unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints